-transparent.png){kind=logo}
A steady-state perfusion technique has been used in vivo in normal subjects to show that at concentrations occurring during therapeutic use (500 mg/1, 1.1 mmol/l) the antibiotic clindamycin reversibly inhibits bicarbonate-stimulated water and electrolyte absorption from the human jejunum. Lactose-stimulated water and electrolyte absorption was not affected by the addition of clindamycin at the same concentration. Clindamycin-induced malabsorption of water and electrolytes may contribute significantly to the diarrhoea that occurs during clindamycin therapy in the absence of pseudomembranous colitis.
Related Publications
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
November 1973,
Gastroenterology,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
February 1981,
Gut,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
June 1987,
Gut,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
July 1980,
Gastroenterology,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
February 1992,
Gastroenterology,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
May 1980,
The Journal of pharmacy and pharmacology,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
May 1976,
Lancet (London, England),
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
October 1996,
Digestive diseases and sciences,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
March 1991,
Gut,
R C Spiller, and
B E Higgins, and
P G Frost, and
D B Silk
March 1978,
Pflugers Archiv : European journal of physiology,
